MMSI
MERIT MEDICAL SYSTEMS INC
-0.38 (-0.44%)85.76USD65.8K成交股數5.1B市值35.3本益比(近四季)3.2股價營收比+9.5%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 419M+18% | 382M+8% | 384M+13% | 382M+13% | 355M+10% | 355M+13% | 340M+6% | 338M+14% | 324M | 315M | 320M | 298M |
| 營業成本 | 204M | 197M | 198M | 198M | 183M | 182M | 182M | 177M | 172M | 173M | 167M | 159M |
| 毛利 | 215M+25% | 185M+7% | 186M+18% | 184M+15% | 172M+13% | 173M+22% | 158M+3% | 161M+16% | 152M | 142M | 153M | 138M |
| 毛利率 | 51.4% | 48.4% | 48.5% | 48.2% | 48.4% | 48.7% | 46.4% | 47.7% | 46.9% | 45.1% | 47.7% | 46.5% |
| 研發費用 | 25.4M | 22.6M | 24.0M | 24.4M | 22.5M | 25.2M | 20.5M | 20.3M | 21.5M | 19.6M | 20.1M | 21.3M |
| 銷售管理費用 | 129M | 118M | 120M | 113M | 107M | 111M | 99.6M | 94.6M | 94.4M | 86.9M | 101M | 90.1M |
| 營業利益 | 60.4M+47% | 44.2M+21% | 42.6M+14% | 46.9M+2% | 41.0M+14% | 36.6M+4% | 37.3M+29% | 45.9M+74% | 35.9M | 35.1M | 28.8M | 26.4M |
| 營業利益率 | 14.4% | 11.6% | 11.1% | 12.3% | 11.5% | 10.3% | 11.0% | 13.6% | 11.1% | 11.1% | 9.0% | 8.9% |
| 稅後淨利 | 38.8M+29% | 41.0M+47% | 27.8M-2% | 32.6M-9% | 30.1M+7% | 27.9M+8% | 28.4M+40% | 35.7M+73% | 28.2M | 25.8M | 20.2M | 20.7M |
| 淨利率 | 9.3% | 10.7% | 7.2% | 8.5% | 8.5% | 7.9% | 8.4% | 10.6% | 8.7% | 8.2% | 6.3% | 7.0% |
| 稀釋 EPS | 0.65+33% | 0.68+48% | 0.46-4% | 0.54-11% | 0.49+2% | 0.46+5% | 0.48+37% | 0.61+69% | 0.48 | 0.44 | 0.35 | 0.36 |
| 稀釋股數 | 60.0M | 60.0M | 59.9M | 60.6M | 61.3M | 59.4M | 59.5M | 58.7M | 58.6M | 58.4M | 58.5M | 58.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 449M | 488M | 392M | 342M | 396M | 377M | 523M | 637M | 582M | 58.7M | 72.1M | 57.9M |
| 應收帳款 | 224M | 206M | 210M | 204M | 200M | 190M | 190M | 182M | 181M | 168M | 171M | 170M |
| 存貨 | 374M | 352M | 327M | 323M | 318M | 306M | 311M | 298M | 303M | 304M | 306M | 290M |
| 總資產 | 2.9B | 2.7B | 2.6B | 2.6B | 2.5B | 2.4B | 2.4B | 2.4B | 2.3B | 1.8B | 1.8B | 1.7B |
| 有息負債 | 736M | 735M | 733M | 732M | 731M | 730M | 751M | 801M | 800M | 282M | 335M | 186M |
| 總負債 | 1.2B | 1.1B | 1.1B | 1.1B | 1.0B | 1.0B | 1.1B | 1.1B | 1.1B | 579M | 634M | 512M |
| 股東權益 | 1.7B | 1.6B | 1.5B | 1.5B | 1.4B | 1.4B | 1.3B | 1.3B | 1.2B | 1.2B | 1.2B | 1.2B |
| 負債比 | 41.3% | 40.2% | 41.9% | 42.5% | 42.1% | 43.0% | 44.3% | 45.9% | 46.7% | 32.0% | 34.5% | 30.4% |
| 淨現金(現金 − 有息負債) | −288M | −247M | −340M | −390M | −335M | −353M | −227M | −165M | −218M | −224M | −263M | −128M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 40.7M | – | – | 40.6M+12% | – | – | – | 36.2M | – | – | 14.5M |
| 資本支出 | – | 16.0M | – | – | 21.1M | – | – | – | 11.7M | – | – | 12.8M |
| 自由現金流 | – | 24.7M | – | – | 19.5M-20% | – | – | – | 24.5M | – | – | 1.8M |
| 折舊攤銷 | 31.0M | 30.5M | 31.3M | 31.0M | 29.3M | 28.6M | 26.4M | 24.1M | 23.6M | – | – | 20.5M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 6.5% | – | – | 5.5% | – | – | – | 7.6% | – | – | 0.6% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 1.5B
| Cardiovascular | 1.4B | 95.2% | +10.9% |
|---|---|---|---|
| Endoscopy | 72.9M | 4.8% | +33.0% |
地區2025 年度 · 1.5B
| 美國 | 909M | 60.0% | +13.6% |
|---|---|---|---|
| 美國以外 | 606M | 40.0% | +9.1% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.5B | +11.8% | 128M | 8.5% | 2.13 | 216M |
| FY2024 | 1.4B | +7.9% | 120M | 8.9% | 2.03 | 186M |
| FY2023 | 1.3B | +9.2% | 94.4M | 7.5% | 1.62 | 111M |
| FY2022 | 1.2B | +7.1% | 74.5M | 6.5% | 1.29 | 69.3M |
| FY2021 | 1.1B | +11.5% | 48.5M | 4.5% | 0.84 | 119M |
| FY2020 | 964M | -3.1% | −9.8M | -1.0% | -0.18 | 119M |
| FY2019 | 995M | +12.7% | 5.5M | 0.5% | 0.10 | −360K |
| FY2018 | 883M | – | 42.0M | 4.8% | 0.78 | 23.2M |